EFNA4-enhanced deubiquitination of SLC7A11 inhibits ferroptosis in hepatocellular carcinoma
Apoptosis · 2025
DOI: 10.1007/s10495-024-02042-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Apoptosis, 2025. Verfasst von Xingyi Zhong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, 510315, China. Hauptthemen laut MEDLINE: Ferroptosis, Carcinoma, Hepatocellular, Liver Neoplasms, Amino Acid Transport System y+. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
EFNA4, a member of the Ephrin-A ligand family, may influence hepatocellular carcinoma cells through two distinct mechanisms: one reliant on specific Eph receptor binding and the other independent of receptor involvement. However, EFNA4's influence on HCC via non-Eph receptor pathways remains unclear. In this study, we aimed to investigate the role of EFNA4 in a receptor-independent environment. Firstly, we constructed an environment lacking Eph receptors via CRISPR/Cas9 and found that EFNA4 could still partially promote HCC proliferation and metastasis in vivo and in vitro. Further analyses of apoptosis, ROS, and GPX4 expression revealed that overexpression of EFNA4 would inhibit ferroptosis in HCC. Mechanistically, EFNA4 was positively correlated with SLC7A11 and directly interacted with SLC7A11 in HCC via bioinformatics analysis. We demonstrated that the structural domain (a.a. 161-201) of EFNA4 specifically binds to the domain (a.a. 222-501) of SLC7A11, which led to the deubiquitination of SLC7A11. Subsequently, we found that EFNA4 would recruit the deubiquitinase USP9X, resulting in inhibition of SLC7A11 degradation, which ultimately inhibits ferroptosis and enhances the proliferation and metastasis of HCC. In conclusion, we demonstrated that EFNA4 promotes the proliferation and metastasis of HCC independent of Eph receptors by inhibiting ferroptosis and advancing the deubiquitination of SLC7A11 by recruiting the deubiquitinase USP9X. This indicates that EFNA4 could act as a potential prognostic marker and a prospective therapeutic target in patients with HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, 510315, China.
- Changde Hospital, Xiangya School of Medicine, Central South University, Changde, 415000, China.
- Department of Pulmonary and Critical Care Medicine, The Third Xiangya Hospital of Central South University, Changsha, 410000, China.
- Fudan University Zhongshan Hospital Xiamen Branch, Xiamen, 361000, China.
- Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, 510315, China. fsc0126@163.com.
Förderung
- Natural Science Foundation of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Zhong, X., Zhu, Z., Du, Y., Long, L., Xie, Z., Zhang, Y., Yao, H., Lin, J., & Chen, F. (2025). EFNA4-enhanced deubiquitination of SLC7A11 inhibits ferroptosis in hepatocellular carcinoma. Apoptosis. https://doi.org/10.1007/s10495-024-02042-4
Vancouver
Zhong X, Zhu Z, Du Y, Long L, Xie Z, Zhang Y, et al. EFNA4-enhanced deubiquitination of SLC7A11 inhibits ferroptosis in hepatocellular carcinoma. Apoptosis. 2025. doi:10.1007/s10495-024-02042-4
BibTeX
@article{Zhong2025,
author = {Zhong, Xingyi and Zhu, Zhiqin and Du, Yangfeng and Long, Lingzhi and Xie, Ziping and Zhang, Yangfeng and Yao, Huijun and Lin, Junhao and Chen, Fengsheng},
title = {EFNA4-enhanced deubiquitination of SLC7A11 inhibits ferroptosis in hepatocellular carcinoma},
journal = {Apoptosis},
year = {2025},
doi = {10.1007/s10495-024-02042-4}
}
EUVIMED